3 Reasons Growth Investors Will Love Cardinal (CAH)
https://www.zacks.com/stock/news/2244383/3-reasons-growth-investors-will-love-cardinal-cah?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_11_growth-2244383
Mar 21, 2024 - Cardinal (CAH) possesses solid growth attributes, which could help it handily outperform the market.
0
GE HealthCare (GEHC) to Sell IONIC's FDA-Cleared nCommand Lite
https://www.zacks.com/stock/news/2246236/ge-healthcare-gehc-to-sell-ionic-s-fda-cleared-ncommand-lite?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2246236
Mar 26, 2024 - GE HealthCare (GEHC) announces the FDA approval of IONIC Health's nCommand Lite technology, which it will distribute for multi-vendor, multi-modality remote operations purposes exclusively.
0
Reasons to Add Veeva Systems (VEEV) to Your Portfolio Now
https://www.zacks.com/stock/news/2246240/reasons-to-add-veeva-systems-veev-to-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2246240
Mar 26, 2024 - Veeva's strong product demand and strategic deals raise optimism about the stock.
0
Abbott's (ABT) Assert-IQ Cardiac Monitor Receives CE Mark
https://www.zacks.com/stock/news/2246922/abbott-s-abt-assert-iq-cardiac-monitor-receives-ce-mark?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2246922
Mar 27, 2024 - Abbott's (ABT) Assert-IQ ICM enables regular monitoring for abnormal heart rhythms, as well as technologies to improve data management and workflow.
0
Here's Why Investors Should Retain STERIS (STE) Stock for Now
https://www.zacks.com/stock/news/2247607/here-s-why-investors-should-retain-steris-ste-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2247607
Mar 28, 2024 - Investors are optimistic about STERIS (STE) on strong Healthcare business performance and raised 2024 guidance.
0
Reasons to Add ShockWave Medical (SWAV) to Your Portfolio Now
https://www.zacks.com/stock/news/2248484/reasons-to-add-shockwave-medical-swav-to-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2248484
Apr 01, 2024 - ShockWave Medical (SWAV) continues to benefit from solid R&D endeavors and its commitment to clinical studies.
0
Reasons to Retain DENTSPLY SIRONA (XRAY) in Your Portfolio Now
https://www.zacks.com/stock/news/2249197/reasons-to-retain-dentsply-sirona-xray-in-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2249197
Apr 02, 2024 - DENTSPLY SIRONA (XRAY) continues to gain traction from a robust product portfolio. However, macroeconomic factors like weakened global demand, rising costs and forex woes persist.
0
Prestige Consumer (PBH) Banks on its Portfolio Amid Cost Woes
https://www.zacks.com/stock/news/2249012/prestige-consumer-pbh-banks-on-its-portfolio-amid-cost-woes?cid=CS-ZC-FT-analyst_blog|zer_report_update-2249012
Apr 02, 2024 - Prestige Consumer (PBH) develops long-term partnerships across its diverse retail footprint and invests heavily in the e-commerce channel.
0
Abbott's (ABT) i-STAT TBI Cartridge Receives FDA Approval
https://www.zacks.com/stock/news/2249322/abbott-s-abt-i-stat-tbi-cartridge-receives-fda-approval?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2249322
Apr 02, 2024 - Abbott's (ABT) i-STAT Alinity instrument uses whole blood to help assess patients with a suspected mild traumatic brain injury or concussion.
0
Here's Why You Should Retain CONMED (CNMD) Stock for Now
https://www.zacks.com/stock/news/2249828/here-s-why-you-should-retain-conmed-cnmd-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2249828
Apr 03, 2024 - CONMED (CNMD) continues to raise optimism among investors, owing to its broad product spectrum.
0